Product NDC: | 10454-712 |
Proprietary Name: | Myobloc |
Non Proprietary Name: | rimabotulinumtoxinB |
Active Ingredient(s): | 10000 [USP'U]/2mL & nbsp; rimabotulinumtoxinB |
Administration Route(s): | INTRAMUSCULAR |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 10454-712 |
Labeler Name: | Solstice Neurosciences, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BLA103846 |
Marketing Category: | BLA |
Start Marketing Date: | 20001208 |
Package NDC: | 10454-712-10 |
Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (10454-712-10) > 2 mL in 1 VIAL, SINGLE-USE |
NDC Code | 10454-712-10 |
Proprietary Name | Myobloc |
Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (10454-712-10) > 2 mL in 1 VIAL, SINGLE-USE |
Product NDC | 10454-712 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | rimabotulinumtoxinB |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR |
Start Marketing Date | 20001208 |
Marketing Category Name | BLA |
Labeler Name | Solstice Neurosciences, LLC |
Substance Name | RIMABOTULINUMTOXINB |
Strength Number | 10000 |
Strength Unit | [USP'U]/2mL |
Pharmaceutical Classes | Acetylcholine Release Inhibitor [EPC],Acetylcholine Release Inhibitors [MoA] |